Trial Profile
Preventive effect for reinfection of human papillomavirus (HPV) 16/18 against cervical intraepithelial neoplasia (CIN) 1
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Jul 2011
Price :
$35
*
At a glance
- Drugs Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune (Primary)
- Indications Cervical cancer; Cervical intraepithelial neoplasia; Human papillomavirus infections
- Focus Diagnostic use
- 02 Jul 2011 New trial record